ABSTRACT 2(3)tert-Butyl4hydroxyanisole (BHA) is one of several widely used antioxidant food additives that protect against chemical carcinogenesis and toxicity. The present report concerns the enhancement of dicoumarolinhibited NAD(P)HL quinone reductase [NAD(P)H dehydrogenase (quinone); NAD(P)H:(quinone acceptor) oxidoreductase, EC 1.6.99.21 activity in mouse tissues in response to dietary administration of BHA. Cytosolic quinone reductase specific activity was increased significantly in 10 of 15 tissues examined from BHA-fed mice. The greatest proportionate increase, to 10 times control levels, was observed in liver. BHA also increased the quinone reductase activities of kidney, lung, and the mucosa of the upper small intestine severalfold. The increases of quinone reductase activities in liver and digestive tissues in response to BHA were comparable to the increases previously observed in glutathione S-transferase (EC 2.5.1.18) and epoxide hydratase (EC 3.3.2.3) activities. Quinones are among the toxic products of oxidative metabolism of aromatic hydrocarbons. NAD(P)H:quinone reductase exhibits broad specificity for structurally diverse hydrophobic quinones an may facilitate the microsomal metabolism of quinones to readily excreted conjugates. The protectie effects of BHA appear to be due, at least in part, to the ability of this antioxidant to increase the activities in rodent tissues of several enzymes involved in the nonoxidative metabolism of a wide variety of xenobiotics.
The widely used antioxidant food additive 2(3)-tert-butyl-4-hydroxyanisole (BHA) has a number of interesting and potentially important pharmacological properties. BHA is a powerful protector against tumor production by a variety of chemical carcinogens (see ref. 1 for a review). It reduces the mutagenic activity of benzo [a] pyrene and other promutagens both in vivo (2) and in vitro (3) (4) (5) and protects animals against the acute toxic effects of mutagenic and carcinogenic compounds (6, 7) . This paper reports large increases in the specific activities of the enzyme NAD(P)H:quinone reductase [NAD(P)H dehydrogenase (quinone); NAD(P)H:(quinone acceptor) oxidoreductase, EC 1.6.99.21 in the cytosols of a number of tissues of albino mice fed a diet containing BHA. These studies are part of a comprehensive analysis of the mechanisms by which antioxidants such as BHA protect against the mutagenic and carcinogenic effects of a variety of chemical compounds (2, (8) (9) (10) (11) (12) (13) . Dietary BHA increases specific activities of cytosolic glutathione S-transferases (EC 2.5.1.18) and microsomal epoxide hydratase (EC 3.3.2.3) in the livers and several other organs of mice and rats (8) (9) (10) 14) and also enhances hepatic UDPglucose dehydrogenase (EC 1.1.1.22) (11, 15) and UDPglucuronyltransferase (1PC 2.4.1.17) activities (11) . Acidsoluble sulfhydryl concentrations are also increased in several mouse tissues (2, 9) . The findings that BHA increases enzymes with broad specificities for electrophiles are noteworthy because
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Administration of BHA to mice has little or no effect on numerous other monooxygenase activities of hepatic microsomes (11, 15, 17) , although ring hydroxylation of aniline is markedly enhanced (11) . Liver microsomes from BHA-fed mice also produce altered patterns of metabolites from benzo[a]pyrene in vitro. Lam and Wattenberg (18) observed decreased epoxidation and increased formation of 3-hydroxybenzo[a]pyrene relative to controls, and these changes were accompanied by a 50% decrease in the binding of metabolites to DNA (19, 20) .
The NADH-and NADPH-linked quinone oxidoreductase here called quinone reductase has also been designated variously as menadione reductase, DT-diaphorase, NAD(P)H dehydrogenase, and vitamin K reductase (21) . Recent studies have shown that rat liver cytosol azoreductase activity for methyl red also reflects the action of quinone reductase (22, 23) . Unusual features of this flavoprotein enzyme include: (i) comparable reaction with NADH and NADPH (24) (25) (26) ; (ti) potent and specific inhibition, in competition with reduced nicotinamide nucleotides, by dicoumarol and related vitamin K antagonists (24, 27) ; (iii) reversible stimulation of activity of the soluble cytosolic quinone reductase by serum albumin, neutral phospholipids, and a number of detergents (24, 26, 27) ; and (iv) broad specificity for a variety of hydrophobic quinones, including benzoquinones, naphthoquinones, ubiquinones, and vitamin K derivatives (24, 25, 28) .
The facile reduction of menadione by this enzyme and its potent inhibition by dicoumarol have focused attention on the possible participation of quinone reductase in the mechanism of vitamin K action. The hydroquinone form of vitamin K is essential for the y-carboxylation of certain glutamyl residues of prothrombin (29) . Removal of residual quinone reductase activity from detergent-solubilized microsomes abolished the "y-carboxylation reaction. This activity could be restored by addition of either homogeneous cytoplasmic quinone reductase or the quinol form of vitamin K (30). 3,5-Di-tert-butyl-4-hydroxytoluene, a phenolic antioxidant that is structurally related to BHA, has been shown to reduce the prothrombin index and to cause hemorrhagic death in rats, whereas BHA was found to be inactive in these respects (31) . Although studies on the toxicity of 3,5-di-tert-butyl-4-hydroxytoluene have revealed that administration of this compound to rats increases hepatic quinone reductase activity severalfold and induces vitamin K deficiency, no causal relationship between these phenomena has been established (32) .
Quinone reductase activity occurs widely in animal, plant, and microbial systems (25) . Highly purified or homogeneous Abbreviations: BHA, 2(3)-tert-butyl-4-hydroxyanisole; quinone reductase, NAD(P)H:(quinone acceptor) oxidoreductase. * To whom reprint requests should be addressed. 5216 preparations have been obtained from beef liver (26) , ox brain (33) , dog liver (28) , and rat liver (24, 30, 34, 35 (42) . Furthermore, the activity of cytosol azoreductase, which is believed to be identical with quinone reductase, is greatly increased by methylcholanthrene administration (43) .
One of the most potent inducers of quinone reductase activity is 2,3,7,8-tetrachlorodibenzo-p-dioxin, which at doses of a few micrograms per kg increases quinone reductase in liver microsomes and cytosol more than 10-fold (40) . This dioxin and many of the polycyclic hydrocarbons also increase aryl hydrocarbon hydroxylase activity, whereas BHA is not active in this respect (11, 14, 19) . Mouse liver quinone reductase is also inducible by aromatic hydrocarbons (45) . Studies on inbred mouse strains (C57BL and DBA) indicate that quinone reductase activity is regulated by two genetic loci distinct from the Ah locus, which controls the responsiveness of aryl hydrocarbon (benzo[a]pyrene) hydroxylase and certain other monooxygenase activities to aromatic hydrocarbon inducers (46) . MATERIALS AND METHODS Female CD-1 mice (Charles River Breeding Laboratories) were housed in stainless steel wire cages and fed a powdered diet of Purina Laboratory Chow. After 20 days of acclimatization, when the mice were 7 weeks old, BHA (Sigma) was added to the diet of half of the mice at a concentration of 7.5 g/kg. Fourteen days later, the mice were killed by cervical dislocation and the tissues were perfused in situ with cold 0.15 M KCl containing 2 mM EDTA (pH 7.0). The gastrointestinal tissues were slit longitudinally and residual food and fecal material were removed. The mucosal surfaces of the upper and lower small intestines and the colons were rinsed and then gently scraped with a spatula and collected. All tissues were frozen in liquid nitrogen and stored at -80°C until further processing.
Cytosol fractions and microsomes were prepared at 0-4°C. Individual tissues were homogenized in 0.25 M sucrose (3.0 ml/g of tissue), except for urinary bladders (0.5 ml per organ) and adrenals (0.2 ml per pair). After centrifugation at 9000 X g for 20 min, the supernatant fluids were collected, 0.2 vol of 0.1 M CaCl2 in 0.25 M sucrose was added to each, and the samples were kept on ice for 30 min. Centrifugation at 27,000 X g for 20 min yielded clear cytosol fractions which were promptly assayed for quinone reductase activity. Liver microsomal pellets were washed twice by suspension in 7 ml of 10 mM Tris-HCI (pH 7.4) in 0.25 M sucrose, resuspended in a volume of this medium equivalent to 5% of the volume of the 9000 X g supernatant from which they were derived, frozen in liquid nitrogen, and stored at -800C. Assays were performed by modifications of the procedures of Ernster (47) . The reaction mixtures contained, in a final volume of 3.0 ml: 25 mM Tris* HC1 (pH 7.4), 0.7 mg of crystalline bovine serum albumin 40 ,MM 2,6-dichloroindophenol (Sigma) in 10,ul of water, were added to initiate the reaction. A somewhat modified procedure, identical in the final concentration of each component, was used for assay of liver microsomes in order to achieve linearity of product formation with time and with enzyme concentration. An appropriate amount of microsomal suspension was added to a cuvette containing 200 Ml of 1% bovine serum albumin (pH 7.4) and 30 Ml of 1% Tween 20. After incubation for 8 min at 250C, Tris HCI, FAD, NADH, and dicoumarol were added in the amounts described above for assay of the cytosol fractions. After an additional 5 min of incubation, the reaction was initiated by addition of the electron acceptor. Assays of the cytosol and microsome preparations were performed at 250C with and without 10 ,M dicoumarol. The dicoumarol-sensitive part of the activity was taken as a measure of the quinone reductase activity. The initial velocity of the reduction of dichloroindophenol was measured spectrophotometrically at 600 nm (aM = 2.1 X 104 M-1 cm'1). With menadione as substrate, either the oxidation of the pyridine nucleotide was followed at 340 nm (aM = 6.27 X 103 M-1 cm'1) or 33 uM cytochrome c (Sigma) was included in the assay medium as a terminal electron acceptor and its reduction was measured spectrophotometrically at 550 nm (aM = 1.85 X 104 M-1 cm-1). All values have been corrected for nonenzymatic rates. Protein concentrations were determined by the method of Lowry et al. (48) . Isoelectric focusing (49) was performed at 1°C with Ampholine solution of pH 3.5-10 (LKB) in sucrose gradients in a 110-ml column (LKB) for 64 hr (1000 V). RESULTS The dicoumarol-sensitive NADH:quinone reductase activity of various mouse tissue cytosols, measured with 2,6-dichloroindophenol, is shown in Table 1 . Administration of BHA to mice resulted in significant increase of cytosol quinone reductase specific activity in 10 of the 15 tissues examined ( Table  1) . The greatest proportionate increase, to 10 times control levels, was observed in liver. Activities in kidney and lung cytosols were increased to 4.2 times and 3.6 times control values, respectively. Five tissues of the gastrointestinal tract were included in this study. In both untreated and BHA-fed mice, the glandular stomach exhibited by far the highest quinone reductase specific activity of all of the tissues examined. This activity increased only 50% as a result of BHA treatment. Activity in forestomach was also quite high and more than doubled in response to BHA. The striking effect of BHA in increasing the quinone reductase activity of the mucosa of the upper small intestine to 5.7 times control values contrasted sharply with its relatively feeble effect in the lower small intestine and colon. BHA had no significant effect on the specific activity of this enzyme in cytosol fractions of thymus, spleen, adrenal, muscle, or fat. It is apparent that rather large differences exist among tissues not only in their basal levels of quinone reductase activity but also in the magnitude of the response of this activity to BHA.
Proc. Natl. Acad. Sci. USA 77 (1980) nmol min-1-mg-' (n = 4) were obtained for untreated and BHA-fed mice, respectively. In each case, the dicoumarolsensitive activity represented 96-99% of the total activity of the liver cytosol.
Attempts to measure quinone reductase activity of mouse hepatic cytosols in the absence of added FAD revealed only feeble activity which declined rapidly in the assay system. Addition-of FAD to the assay medium at concentrations of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] ,MM yielded optimal enzymatic activity and excellent linearity of product formation with time as well as with the concentration of cytosol in the assay system. FMN also enhanced activity but was less effective than FAD. At optimal concentrations of FAD, addition of FMN yielded no further increase in activity.
Isoelectric focusing of liver cytosol from untreated mice resulted in the recovery (69%) of the quinone reductase activity measured with 2,6-dichloroindophenol in a peak corresponding to an isoelectric point of 9.7 + 0.2. Under the standard assay conditions with 2,6-dichloroindophenol and NADH, the peak fraction exhibited a Km of 2.6 nM for FAD. Half-maximal inhibition was observed at a dicoumarol concentration of 0.19 ,M, and 10 AM dicoumarol inhibited 98% of the activity. In the enzymatic reduction of menadione by NADH with cytochrome c as terminal electron acceptor, the Km for menadione was 0.22 ± 0.02 ,M. Isoelectric focusing of liver cytosol from BHA-fed mice yielded 62% recovery of quinone reductase activity. This preparation was indistinguishable from that derived from untreated mice both in its isoelectric pH (9.7) and in its Km for menadione (0.20 I 0.01 ,M). DISCUSSION The increases in cytosolic quinone reductase specific activities in mouse liver as well as in digestive tract tissues in response to BHA were comparable to the increases of cytosolic-glutathione S-transferase and microsomal epoxide hydratase specific activities observed previously in these tissues (8) (9) (10) . In liver, all of these activities increased dramatically and to similar extents in mice receiving the BHA diet. Among the digestive tract tissues examined, the mucosa of the upper small intestine exhibited the largest increases of quinone reductase activity as well as glutathione S-transferase activities (unpublished observation). It is of interest that the highest activities of quinone reductase were observed (both on control and BHA diets) in tissues of the gastrointestinal tract (stomach, small intestine, and colon) and the urinary tract (kidney and bladder). It might be suggested that these high activities are an evolutionary adaptation in response to the exposure of these tissues to high levels of toxic, mutagenic, and carcinogenic substances.
In lung, where epoxide hydratase activity increased only minimally and glutathione S-transferase activity doubled in response to BHA (9) , quinone reductase activity was increased to 3.6 times control levels. The increase in quinone reductase specific activity to 4.2 times control levels in kidney contrasted with the modest increases in epoxide hydratase and glutathione S-transferase activities previously observed in this organ (9) .
The very high activities of all three types of enzymes in the urinary bladder seem quite remarkable.
A variety of structurally diverse inducers of quinone reductase activity have in common the ability to confer protection against the biological effects of certain carcinogenic and toxic substances. These inducers include BHA, 3,5-di-tert-butyl- 4 caused by this hydrocarbon (6) . Hemorrhage and necrosis of the adrenal cortex in the rat after administration of 7J,1T2-dimethylbenrz[a]anthracene, which was first described by Huggins and Morii (50) , can be prevented by prior treatment with small doses of the same hydrocarbon or with various other aromatic compounds (38, 51 (52) .
Quinones are among the toxic products of the oxidative metabolism of aromatic hydrocarbons (53) . Studies on five quinone derivatives of benzo[a Ipyrene revealed that none was a direct mutagen for Salmonella typhimurium or Chinese hamster V79 cells (54) . However (54) .
The reduction of quinones can lead either to their detoxification or to the production of biologically reactive products, depending upon the mechanism of the reduction and upon the subsequent disposition of the hydroquinone products. NADPH cytochrome P-450 reductase catalyzes the one-electron reduction of quinones to semiquinone radical anions capable of damaging DNA, RNA, and other essential cellular macromolecules (56) . Although NAD(P)H-quinone reductase catalyzes the reduction of a wide variety of quinones to the corresponding hydroquinones (24, 25) , the generation of semiquinone radicals by this enzyme has not been reported nor has it been established whether semiquinones can serve as substrates. Insufficent information on the catalytic mechanism is available to clarify these points.
Studies on several benzo[a]pyrene quinones have revealed that the hydroquinone products undergo autooxidation via semiquinone radical intermediates, with concomitant generation of superoxide radicals, hydrogen peroxide, and possibly hydroxyl radicals (57, 58) . Enzymatic reduction of quinones can thus perpetuate a cyclic process of interconversion of quinones and hydroquinones with generation of reduced oxygen species and depletion of reduced pyridine nucleotide (57, 59 (60) .
It may be noteworthy that at least three of the enzymes whose activities in rodent livers are increased substantially in response to BHA-namely, quinone reductase, epoxide hydratase (10) , and glucose-6-phosphate dehydrogenase (11)-are also increased in the preneoplastic state (61) (62) (63) . The activity of quinone reductase is greatly increased in transplantable Morris hepatomas (61) and in preneoplastic foci and hyperplastic nodules produced in rat liver by the carcinogen, 2-acetylaminofluorene (62) . Such hyperplastic nodules also exhibit severalfold increased glucose-6-phosphate dehydrogenase (62) and epoxide hydratase activities (63) . The implications of these findings are not yet clear but may include increased cellular resistance to toxicity (62) as well as a relationship of some of these enzymes to the regulation of cell growth and neoplasia (63) . This investigation was supported by National Institutes of Health Grants GM 16492 and CA 18291.
